Locus Cell Co., Ltd.
↗New Taipei City, Taiwan
Locus Cell Co., Ltd. is a Taiwan-based biotechnology company specializing as a Contract Development and Manufacturing Organization (CDMO) for regenerative medicine and cell therapy products. The company focuses on providing process development, analytical method validation, and clinical GMP manufacturing services for advanced therapies, including CAR-T, iPSCs, and MSC applications.
Operating out of a PIC/S GMP-compliant facility in the Hsinchu Biomedical Science Park, Locus Cell aims to bridge the gap between research and commercialization for cell therapy developers. The company is actively pursuing international regulatory certifications, including from the US FDA and Japan's PMDA, to support its expansion into broader Asian and global markets.
CLASSIFICATION
SIZE & FINANCIALS
Employees:51-200
Revenue:$0.1M-$1M
Founded:2021
Ownership:public
Status:operating
FUNDING
Investors:MetaTech AP
STOCK
Exchange:TPEX
Ticker:6891
Market Cap:$0.16B
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (CDMO Service Provider)
Modalities:Cell therapy
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:MetaTech AP (Joint venture partner)
COMPETITION
Position:Niche Player
LINKS
Website:locus-cell.com
LinkedIn:LinkedIn Profile
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Locus Cell Co., Ltd. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Locus Cell Co., Ltd.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.